Ulipristal Acetate: The Five-Day Emergency Contraception Pill
The "5 day pill" is a common term referring to **Ulipristal Acetate** (UPA), a form of hormonal emergency contraception (EC) that maintains high efficacy for up to 120 hours, or five full days, following unprotected sexual intercourse. UPA represents a significant advance in reproductive options, providing a much wider window of opportunity compared to older, Levonorgestrel-based pills (like Plan B) which are most effective within 72 hours.
As a specialist, I confirm that emergency contraception is a time-sensitive intervention. Understanding the specific mechanism of UPA, its higher efficacy, and the key difference between UPA and other pills is essential for ensuring the highest chance of preventing an unintended pregnancy.
Table of Contents
1. Mechanism of Action: Delaying Ovulation
Ulipristal Acetate (UPA) is a **Selective Progesterone Receptor Modulator (SPRM)**. This means it acts on the body’s progesterone receptors, disrupting the normal hormonal cascade required for ovulation. UPA's action is focused almost entirely on preventing the release of an egg.
The Role of the LH Surge
Pregnancy occurs when an egg is released (ovulation) and is met by sperm. Ovulation is triggered by a surge of Luteinizing Hormone (LH). UPA works by delaying or suppressing this LH surge. Crucially, UPA is effective even when taken immediately before the LH surge begins, a time when Levonorgestrel is generally ineffective.
Primary Function: UPA prevents pregnancy by inhibiting or delaying **ovulation**. It works by binding to the progesterone receptor, suppressing the hormonal signal that would normally lead to the egg's release. If no egg is released, fertilization cannot occur.
Important Note: Like all forms of hormonal emergency contraception (EC), UPA is not an abortion pill. It cannot terminate an established pregnancy; it only works to prevent conception from occurring.
2. UPA vs. Levonorgestrel (Plan B): The Key Differences
The "5 day pill" (UPA) maintains its high efficacy throughout the entire 120-hour window, whereas the 3-day pill (Levonorgestrel/Plan B) rapidly declines in effectiveness after the first 24 hours.
Key Comparison Points
| Factor | Ulipristal Acetate (e.g., Ella) | Levonorgestrel (e.g., Plan B) |
|---|---|---|
| Max Time Window | 120 Hours (5 Days) | 72 Hours (3 Days) |
| Efficacy at Day 3 | Maintains high efficacy (no significant drop). | Effectiveness significantly reduced. |
| Mechanism | Selective Progesterone Receptor Modulator (SPRM). | High-dose Progestin. |
| Prescription Required? (US) | Yes (Requires prescription). | No (Available Over-the-Counter). |
| Weight Limit Note | More effective for individuals with higher BMI (up to 195 lbs). | Efficacy may decrease significantly over 165 lbs. |
3. Access, Timing, and Efficacy
The critical barrier to UPA access is the prescription requirement, which makes immediate action challenging. However, because its efficacy is sustained across the five days, it is the superior choice if more than 72 hours have passed since unprotected intercourse, or if the individual has a higher BMI.
The Time-Sensitive Decision
- Action is Paramount: All EC methods work best the sooner they are taken. The 5-day window for UPA is a maximum allowance, not a delay recommendation.
- Prescription Process: Because UPA requires a prescription, access often involves a consultation with a healthcare provider or a tele-health appointment.
- Drug Interaction: If you are taking hormonal birth control (pills, patch, ring), you must **wait five full days** after taking UPA before starting or resuming the hormonal method, as the hormonal birth control can interfere with UPA's effectiveness.
4. Expected Side Effects and Menstrual Changes
The side effects of UPA are generally mild and temporary, reflecting the powerful hormonal intervention, but they do not pose long-term health risks.
Physiological Responses to UPA
- Next Period Timing: The most common side effect is a change in the next menstrual period. The period may arrive a few days earlier or be delayed by more than a week. A delay of more than seven days warrants taking a pregnancy test.
- Spotting: Light, irregular bleeding or spotting between the time of administration and the next period is common.
- General Discomfort: Mild and temporary symptoms may include headache, nausea, abdominal pain, and fatigue.
- Vomiting Protocol: If vomiting occurs within three hours of taking the UPA pill, immediately contact your provider, as a repeat dose may be required to ensure effectiveness.
5. Addressing Safety and Pregnancy Status
Emergency contraception is designed solely to prevent pregnancy; it is not an abortion method and cannot harm an established pregnancy.
Safety and Future Fertility
- No Risk to Existing Pregnancy: If a person is unknowingly pregnant when UPA is taken, the medication will not terminate the pregnancy nor has it been linked to birth defects. However, UPA should not be used if pregnancy is confirmed.
- Future Fertility: UPA has no long-term impact on a person's ability to conceive in future cycles. Fertility returns almost immediately after the medication's effect wears off.
- Test if Period is Late: If the next period is more than one week late after taking UPA, take a home pregnancy test to confirm status.
Ulipristal Acetate (the 5-day pill) provides a valuable, highly effective lifeline in emergency contraception, especially in the 72 to 120-hour window. Acting quickly and understanding the specific mechanism of UPA ensures you maximize its protective benefits against unintended pregnancy.
